Extending the Shelf Life of Doxorubicin Loaded PLGA Nanoparticles with Cryoprotectants DOI Open Access
Tuğba Koldankaya, Serap Mert

ChemistrySelect, Journal Year: 2024, Volume and Issue: 9(41)

Published: Oct. 28, 2024

Abstract Sugars, as cryoprotectants, can be added to NP formulations before lyophilization ensure that NPs retain their size during long‐term storage. In this study, mannitol, glucose, and sucrose were used at different concentrations extend the storage time of doxorubicin (DOX)‐loaded PLGA‐NPs prepared using two copolymer ratios (75 : 25 50 50) temperatures (−20, +4, +25 °C). After lyophilization, a glucose or concentration only 5 % for DOX‐PLGA‐75 25‐NP 10 DOX‐PLGA‐50 50‐NP found prevent agglomeration up 4 months −20 °C. It is noteworthy after °C months, was prevented in content both types. On other hand, expected, no sugar type could The sizes encapsulation efficiencies (EE%) 221.8±2.20 45.4 221.5±1.31 48.7 25‐NP, respectively. Furthermore, release profiles DOX investigated by UV‐Vis analyses. DSC analysis revealed present free form amorphous NPs. Consequently, PLGA have an impact on stability loaded lyophilizates, DOX‐loaded with 75 stored +4 when combined appropriate contents concentrations, demonstrating versatility these materials.

Language: Английский

Hyaluronic acid/lactoferrin–coated polydatin/PLGA nanoparticles for active targeting of CD44 receptors in lung cancer DOI
Ahmed Nashaat Alnagar, Amira Motawea,

Khaled M. Elamin

et al.

Pharmaceutical Development and Technology, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 17

Published: Oct. 11, 2024

Traditional chemotherapeutic drugs lack optimal efficacy and invoke severe adverse effects in cancer patients. Polydatin (PD), a phytomedicine, has gradually gained attention due to its antitumor activity. However, low solubility poor bioavailability are still cornerstone issues. The present study aimed fabricate develop hyaluronic acid/lactoferrin-double coated PD/PLGA nanoparticles

Language: Английский

Citations

2

Multicenter proteome-wide Mendelian randomization study identifies causal plasma proteins in melanoma and non-melanoma skin cancers DOI Creative Commons
Yajia Li, Qiangxiang Li, Ziqin Cao

et al.

Communications Biology, Journal Year: 2024, Volume and Issue: 7(1)

Published: July 13, 2024

Abstract This study addresses the diagnostic and therapeutic challenges in malignant melanoma (MM) non-melanoma skin cancers (NMSC). We aim to identify circulating proteins causally linked MM NMSC traits using a multicenter Mendelian randomization (MR) framework. utilized large-scale cis-MR estimate impact of numerous plasma on MM, NMSC, squamous cell carcinoma (SCC), basal (BCC). To ensure robustness, additional analyses like MR Steiger Bayesian colocalization are conducted, followed by replication through meta-analytical methods. The associations between identified outcomes also validated at tissue level Transcriptome-Wide Association Study Furthermore, protein-protein interaction analysis is conducted explore relationship existing cancer medication targets. has 13 with BCC, 2 SCC, 1 MM. Specifically, ASIP KRT5 associated potentially targeting CTSS TNFSF8 as promising druggability candidates for BCC. multidimensional approach nominates ASIP, KRT5, CTSS, potential targets cancers.

Language: Английский

Citations

1

Advances in polymer-centric nanomedicines for theranostic cancer treatment DOI

Anindita Bag,

Rahul Maheshwari

Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 100, P. 106105 - 106105

Published: Aug. 28, 2024

Language: Английский

Citations

1

Recent approaches for the treatment of uveal melanoma: Opportunities and challenges DOI
Sauban Ahmed Khan, Waleed Hassan Almalki,

Swaranjeet Arora

et al.

Critical Reviews in Oncology/Hematology, Journal Year: 2023, Volume and Issue: 193, P. 104218 - 104218

Published: Nov. 30, 2023

Language: Английский

Citations

3

Extending the Shelf Life of Doxorubicin Loaded PLGA Nanoparticles with Cryoprotectants DOI Open Access
Tuğba Koldankaya, Serap Mert

ChemistrySelect, Journal Year: 2024, Volume and Issue: 9(41)

Published: Oct. 28, 2024

Abstract Sugars, as cryoprotectants, can be added to NP formulations before lyophilization ensure that NPs retain their size during long‐term storage. In this study, mannitol, glucose, and sucrose were used at different concentrations extend the storage time of doxorubicin (DOX)‐loaded PLGA‐NPs prepared using two copolymer ratios (75 : 25 50 50) temperatures (−20, +4, +25 °C). After lyophilization, a glucose or concentration only 5 % for DOX‐PLGA‐75 25‐NP 10 DOX‐PLGA‐50 50‐NP found prevent agglomeration up 4 months −20 °C. It is noteworthy after °C months, was prevented in content both types. On other hand, expected, no sugar type could The sizes encapsulation efficiencies (EE%) 221.8±2.20 45.4 221.5±1.31 48.7 25‐NP, respectively. Furthermore, release profiles DOX investigated by UV‐Vis analyses. DSC analysis revealed present free form amorphous NPs. Consequently, PLGA have an impact on stability loaded lyophilizates, DOX‐loaded with 75 stored +4 when combined appropriate contents concentrations, demonstrating versatility these materials.

Language: Английский

Citations

0